Unilab
Unilab is the leading pharmaceutical company in the Philippines, manufacturing and distributing over 500 prescription, OTC, vitamin, supplement, and personal care brands through eight domestic facilities and nationwide pharmacy and e-commerce channels to Filipino consumers.
- Company typePrivate
- Founded1945
- HeadquartersMandaluyong, Philippines
- Headcount1,001–5,000
- GTM typeB2C
- OfferingHardware or Manufacturing
What Unilab does
Unilab (United Laboratories, Inc.) is the leading pharmaceutical company in the Philippines, founded in 1945 in post-war Manila by Jose Y. Campos and Mariano K. Tan and still controlled by the Campos family under Chairman and CEO Clinton Campos Hess. The company manufactures and distributes more than 500 brands of affordable prescription and OTC pharmaceutical products, vitamins, supplements, and personal care items across nine wholly-owned subsidiaries covering cancer care (BIO-ONCO), women's health (Biofemme), critical care (Biomedis), chronic disease (LRI Therapharma), mental health (Medichem), pediatrics (Pediatrica), respiratory (UAP), consumer health (Biogesic, Neozep, Enervon, Alaxan), and gastrointestinal therapeutics (Westmont).
Unilab operates eight manufacturing facilities across the Philippines, with Amherst Laboratories in Laguna as the largest plant and the first pharmaceutical site in the country declared compliant with both European Union and Singapore Good Manufacturing Practices standards. Products reach consumers through nationwide pharmacy partnerships with Mercury Drug, Rose Pharmacy, and Watsons Philippines, supplemented by a direct-to-consumer e-commerce shop at unilab.com.ph and direct sales to hospitals and clinics. Pricing follows unit-based retail pricing (e.g., Alnix tablet at Php32.50 SRP) and prescription dispensing.
The company generates revenue across four principal streams: prescription pharmaceuticals, OTC medicines, vitamins and supplements, and personal care, with horizontal segmentation across therapeutic areas. Unilab has expanded beyond medicines into integrated health products, health services, and animal healthcare under the Unilab Group umbrella. Strategic priorities evidenced in 2025 include a multi-year digital transformation partnership with Tata Consultancy Services, exploratory ASEAN cross-border engagement with the Singapore Manufacturing Federation, sustainability investments such as a 500-kilowatt solar installation at Amherst Parenterals, and government advocacy for Philippine pharmaceutical self-sufficiency. The company holds a 30.5% combined market share with Haleon plc in the Philippine vitamin and dietary supplement market (2023 data) and does not publicly disclose consolidated revenue.
Unilab firmographics
Firmographics- Name
- Unilab
- Legal name
- United Laboratories
- Website
- https://unilab.com.ph
- Company type
- Private
- Founded year
- 1945
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Unilab is the leading pharmaceutical company in the Philippines, manufacturing and distributing over 500 prescription, OTC, vitamin, supplement, and personal care brands through eight domestic facilities and nationwide pharmacy and e-commerce channels to Filipino consumers.
- Ownership category
- akta.pro rank
Unilab industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)
- akta.pro secondary industries
- Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Children’s Vitamins & Supplements (CRADAGAJ), OTC & Consumer Health Distributors (HLAIAJAC), Respiratory & Allergy Pharmaceuticals (HLAIAAAH)
Keywords
Where Unilab is headquartered
LocationHeadquarters
- HQ city
- Mandaluyong
- HQ country
- Philippines
- HQ region
- Asia
Offices2 records
Markets served
Unilab business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Prescription Pharmaceuticals: Revenue from prescription medicines across multiple therapeutic areas including cancer care, cardiovascular, respiratory, metabolic health, and more through subsidiaries like BIO-ONCO, LRI Therapharma, UAP, and others.
- Over-the-Counter (OTC) Medicines: Revenue from OTC products including Biogesic, Neozep Z+, Enervon Z+, Alaxan, Alnix, and other consumer health products sold through retail pharmacies.
- Vitamins and Supplements: Revenue from vitamin and supplement products for children and adults including Ceelin, Forti-D, ImmunPro, and others.
- Personal Care: Revenue from oral care, skin care, and other personal care products under the Unilab Consumer Health portfolio.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Alnix Tablet - Cetirizine Dihydrochloride OTC allergy relief |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels6 records
Unilab product offering
Product offeringCore offering
Unilab (United Laboratories, Inc.) manufactures and distributes a portfolio of over 500 brands of affordable prescription and OTC pharmaceutical products in the Philippines. The company's offerings span allergy relief, children's medicines and vitamins, cough and cold remedies, pain relief, digestive care, vitamins, supplements, and prescription drugs across therapeutic areas including cancer care, cardiovascular, respiratory, metabolic health, women's health, and pediatrics through wholly-owned subsidiaries such as BIO-ONCO, LRI Therapharma, Pediatrica, and Unilab Consumer Health. Products reach consumers through pharmacy chains (Mercury Drug, Rose Pharmacy, Watsons), the company's own e-commerce shop, and healthcare provider channels.
Product overview
Unilab (United Laboratories, Inc.) is the leading pharmaceutical company in the Philippines, offering a comprehensive portfolio of over 500 brands of affordable, quality prescription and OTC products. The company operates across multiple therapeutic categories including allergy relief (Alnix, Alnix Plus, Allerta), children's medicines and vitamins (Ceelin, Ceelin Gummies, Ceelin Immunped, Ferlin Vita, PowerCeez, Appebon Kid), cough and cold remedies (Solmux, Neozep, Decolgen), pain relief (Biogesic, Alaxan), digestive care (Diatabs, Kremil-S), vitamins and supplements (Enervon, Forti-D, ImmunPro), and prescription drugs (Exflem Granules). The company also offers specialized products through subsidiaries including Bio-ONCO (cancer care), Biofemme (women's health), Biomedis (critical care), LRI Therapharma (chronic conditions), Medichem (mental health), Pediatrica (pediatrics), UAP (respiratory), Unilab Consumer Health (brands like Biogesic, Enervon Z+, Neozep Z+, Alaxan), and Westmont (gastrointestinal).
Differentiator
Problem solved
Functional benefit
Brands
- BIO-ONCO: Cancer care subsidiary focused on holistic healing through hormone therapy and chemotherapy treatments
- Biofemme
- Biomedis
- LRI Therapharma
- Medichem
- Pediatrica
- United American Pharmaceuticals (UAP)
- Unilab Consumer Health
- Westmont
Products and services
- Alnix Tablet Cetirizine Dihydrochloride anti-allergy medicine providing fast-acting, all-day relief from allergic rhinitis symptoms including sneezing, runny nose, itchy nose, and itchy watery eyes. Targeted at Filipino consumers seeking OTC allergy relief.
- Alnix Plus Tablet Combination antihistamine and decongestant (Cetirizine + Phenylephrine HCl) providing immediate relief from allergic rhinitis symptoms including clogged nose, sneezing, runny nose, and itchy eyes. Targeted at Filipino consumers needing stronger allergy symptom management.
- Allerta Non-drowsy allergy relief medication for allergy symptom management, targeted at Filipino consumers who need daytime symptom relief without sedation.
- Ceelin Gummies Gummy vitamin supplement that helps support children's immunity when combined with proper diet and exercise. Targeted at Filipino parents seeking child-friendly vitamin delivery formats.
- Ceelin Immunped Food supplement designed to support immune function in children, targeted at Filipino parents seeking pediatric immune system support.
- Ferlin Vita Iron supplement formulated for babies and children with appealing taste to support healthy development. Targeted at Filipino parents addressing pediatric iron deficiency.
- PowerCeez (Marvel-themed Vitamin C + Zinc Syrup) Vitamin C and Zinc syrup in Marvel-themed packaging designed to support children's immune defenses. Targeted at Filipino parents seeking pediatric immunity support with child-appealing branding.
- Solmux Throat Spray Throat spray for targeted relief of itchy sore throat symptoms. Targeted at Filipino consumers seeking convenient sore throat relief.
- Appebon Kid Chewables Chewable supplement designed to help improve children's appetite. Targeted at Filipino parents concerned about child nutrition and appetite.
- Diatabs Advance Anti-diarrheal medication providing total relief from diarrhea and stomach pain. Targeted at Filipino consumers treating acute gastrointestinal distress.
- Enervon Z+ Tablet Multivitamin supplement that sustains overall health with extra energy support. Targeted at Filipino adults seeking daily multivitamin and energy support.
Quantifiable outcome
- 30.5% combined market share in Philippine vitamin and supplement market (alongside Haleon plc)
- +1 more outcomes
Companies that use Unilab
Customer profileNamed customers3 records
Segments9 records
Ideal customer profiles2 records
Unilab technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Unilab partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core, flagship and minor.
- Tata Consultancy Services (TCS)coreTCS announced expanded partnership with Unilab as part of their Q2 FY26 results. TCS serves as a technology services partner providing digital transformation capabilities for Unilab's operations modernization.
- Singapore Manufacturing FederationcoreSingapore Manufacturing Federation hosted a cross-border pharmaceutical and medical technology industry exchange with Philippine partners on 26 August 2025. Unilab Inc. participated in discussions on distribution of medical devices and pharmaceuticals, clinical trial partnerships, and regulatory frameworks including PIC/S inspections.
- Watsons PhilippinescoreWatsons Philippines hosts the Watsons HWB Awards celebrating collaborative partnerships with leading health, wellness, and beauty brands. Unilab products are distributed through Watsons' 1,200+ stores nationwide as part of A.S. Watson Group's network spanning 30 markets.
- Philippine House of Representatives (Committee on Trade and Industry and Committee on Health)flagshipHouse Committee on Trade and Industry Chair Rep. Maximo Dalog Jr. and House Committee on Health Chair Rep. Ciriano B. Gato Jr. visited Unilab's Amherst Laboratories facility to understand the state of local pharmaceutical manufacturing, supporting President Ferdinand Marcos Jr.'s vision for the Philippines to become a self-sufficient pharmaceutical hub in ASEAN.
- Hepmil PhilippinesminorHepmil Philippines, a creator network with nearly 600 talents, has developed campaigns for Unilab as one of their major brand clients, demonstrating content marketing and influencer partnership capabilities.
- BIO-ONCOcoreSubsidiary specializing in holistic cancer care through hormone therapy and chemotherapy treatments.
- BiofemmecoreSubsidiary providing preventive and therapeutic solutions for women's health across every stage of their lives.
- BiomediscoreSubsidiary providing renal, surgical, and critical care solutions for optimal health and recovery.
- LRI TherapharmacoreSubsidiary providing trusted, quality, and affordable medicines for hypertension, diabetes, stroke, and other chronic conditions.
- MedichemcoreSubsidiary providing mental health products with commitment to supporting patients, families, and caregivers.
- PediatricacoreSubsidiary focusing on tailored healthcare solutions for children's different needs.
- United American Pharmaceuticals (UAP)coreSubsidiary specializing in respiratory solutions to help people breathe freely.
- Unilab Consumer HealthcoreSubsidiary empowering Filipinos with trusted brands including Biogesic, Enervon Z+, Neozep Z+, and Alaxan.
- WestmontcoreSubsidiary specializing in gastro-intestinal solutions including antibiotics, anti-hypertensives, anti-ulcer, anti-inflammatory, and clinical nutrition.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Unilab competitors and assessment
Company assessmentDirect peers
- Haleon plc: Co-leader with Unilab in the Philippine vitamin and dietary supplement market with a combined 30.5% share in 2023. Haleon (formerly GSK Consumer Healthcare) directly competes with Unilab's Enervon, ImmunPro, and Ceelin lines across vitamins and OTC consumer health.
Regional players
- PT Kalbe Farma: Indonesia's largest pharmaceutical company with a similar portfolio mix of branded generics, OTC, consumer health, and supplements. Operates in Southeast Asia's largest pharma market, making it a useful peer for Unilab's regional expansion ambitions.
Broad incumbents
- Pfizer: Global pharmaceutical major with a Philippines commercial presence, competing with Unilab in respiratory, oncology, and primary care categories. Represents the multinational incumbent competition that increasingly targets Unilab's segments.
- GSK: Multinational pharma and vaccines company whose former consumer health business is now Haleon. Competes with Unilab in respiratory, vaccines, and consumer health, and is a relevant comparator for branded pharma + consumer health bundling.
- Bayer: Global pharma and consumer health player with broad therapeutic and OTC portfolios. Comparable to Unilab in combining prescription pharmaceuticals with consumer health brands across emerging Asia.
- Johnson & Johnson: Multinational pharma, medical devices, and consumer health company with a strong Philippines presence. Direct overlap with Unilab in OTC, personal care, and selected therapeutic categories.
- Sanofi: Global pharmaceutical company with a meaningful consumer healthcare (OTC) business competing with Unilab in allergy, cold/flu, and chronic disease categories in the Philippines.
- Abbott: Global healthcare company with established pharmaceutical, nutritional, and consumer health businesses. Comparable to Unilab in combining pharma manufacturing with nutritional supplements and OTC products in emerging Asia.
Emerging players
- Mega Lifesciences: Thai-based branded generics and consumer health company operating across Southeast Asia, the Middle East, and Africa. Comparable in therapeutic breadth, distribution-led model, and emerging-market focus.
- Taisho Pharmaceutical: Japanese pharmaceutical company with a strong OTC and consumer health franchise across Asia. Comparable to Unilab in its emphasis on mass-market OTC brands and selective international expansion in Southeast Asia.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Unilab social profiles
Digital presenceUnilab compliance and trust
Trust signalCompliance2 records
Unilab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Unilab leadership team
Management profileNumber of profiles
Profiles2 records
Unilab subsidiaries and ownership
Company hierarchySubsidiaries9 records
Unilab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Unilab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Unilab
What does Unilab do?
Unilab (United Laboratories, Inc.) manufactures and distributes a portfolio of over 500 brands of affordable prescription and OTC pharmaceutical products in the Philippines. The company's offerings span allergy relief, children's medicines and vitamins, cough and cold remedies, pain relief, digestive care, vitamins, supplements, and prescription drugs across therapeutic areas including cancer care, cardiovascular, respiratory, metabolic health, women's health, and pediatrics through wholly-owned subsidiaries such as BIO-ONCO, LRI Therapharma, Pediatrica, and Unilab Consumer Health. Products reach consumers through pharmacy chains (Mercury Drug, Rose Pharmacy, Watsons), the company's own e-commerce shop, and healthcare provider channels.
Is Unilab a public or private company?
Unilab is a private company. It is classified as family owned and is currently operating.
When was Unilab founded?
Unilab was founded in 1945. It employs 1,001 to 5,000 people.
Where is Unilab based?
Unilab is headquartered in Mandaluyong, Philippines, in the Asia region.
How does Unilab make money?
Four revenue lines are on record. Prescription Pharmaceuticals are the primary driver. The others are over-the-Counter (OTC) Medicines, vitamins and Supplements and personal Care.
Who are Unilab's main competitors?
Haleon plc is listed as a direct peer. PT Kalbe Farma is listed as a regional player. Broad incumbents are Pfizer, GSK, Bayer, Johnson & Johnson, Sanofi and Abbott. Emerging players are Mega Lifesciences and Taisho Pharmaceutical.
Does Unilab have an API?
No public API is recorded for Unilab.
What industry is Unilab in?
Unilab's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is CRAOAHAB, OTC Medicines & Consumer Health Products Distribution, with a secondary code of CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges). Its NAICS code is 3254 and its SIC code is 2834.